A Study to Compare the Investigational Formulations (Soft Gelatin Capsules of MDC8) of Dutasteride With the Marketed Soft Gelatin Capsule Formulation in Healthy Male Volunteers

Trial Profile

A Study to Compare the Investigational Formulations (Soft Gelatin Capsules of MDC8) of Dutasteride With the Marketed Soft Gelatin Capsule Formulation in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jul 2016

At a glance

  • Drugs Dutasteride (Primary)
  • Indications Alopecia; Benign prostatic hyperplasia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 08 Jul 2016 New trial record
    • 29 Jun 2016 Primary endpoint has not been met. (Cmax), as per results published in the Clinical Drug Investigation.
    • 29 Jun 2016 Primary endpoint has been met. (AUC from time zero to 72 h (AUC72)), as per results published in the Clinical Drug Investigation.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top